Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 0.40% Nasdaq Up 0.97%
Streaming
Ticker Tape: On

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
3.89 0.26(7.16%) Apr 22, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:3.63
Open:3.66
Bid:3.83 x 1000
Ask:3.98 x 1500
1y Target Est:9.50
Beta:1.64
Next Earnings Date:N/A
Day's Range:3.66 - 3.95
52wk Range:3.20 - 7.45
Volume:1,096,232
Avg Vol (3m):1,423,550
Market Cap:270.65M
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 7.16%270.65M
DNDN410.99M
NKTR1.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.37
Quarterly EPS Est (Mar-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback